北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
ACEI/ARB Underused in Patients with Type 2 Diabetes in Chinese Population (CCMR-3B Study)
作者: Xie, Qionghong1; Hao, Chuan-Ming1; Ji, Linong2; Hu, Dayi3; Zhu, Tongying1; Li, Xuehai4; Qin, Dandan4; Zhang, Danyi4
刊名: PLOS ONE
发表日期: 2015-02-12
DOI: 10.1371/journal.pone.0116970
卷: 10, 期:2
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Multidisciplinary Sciences
研究领域[WOS]: Science & Technology - Other Topics
关键词[WOS]: CONVERTING ENZYME-INHIBITORS ; CORONARY-HEART-DISEASE ; RENAL-DISEASE ; RECEPTOR BLOCKERS ; ACE-INHIBITORS ; NEPHROPATHY ; MELLITUS ; IRBESARTAN ; COMPLICATIONS ; EPIDEMIOLOGY
英文摘要:

Objective

In patients with diabetic kidney disease, it is well documented that RAS blockade is associated with an improved outcome. This observational, multicenter study examined the "real-world" use of ACEI/ARB in patients with type 2 diabetes (T2DM) in China.

Method

Data from the China Cardiometabolic Registries on blood pressure, blood lipid and blood glucose in Chinese T2DM patients (CCMR-3B) were used for the present study. Consecutive outpatients with T2DM for more than 6 months were recruited to this non-interventional, observational, cross-sectional study. Albuminuria was defined as urine albumin creatinine ratio (ACR) >= 30mg/g.

Results

A total of 25,454 outpatients with T2DM from 6 regions in China were enrolled, 47.0% were male, and 59.8% had hypertension. ACR was measured in 6,383 of these patients and 3,231 of them >= 30mg/L. Among patients with hypertension, 73.0% were on antihypertensives, and 39.7% used ACEI/ARB. Of the 2,157 patients with hypertension and albuminuria, only 48.3% used ACEI/ARB. Among the non-hypertensive patients with albuminuria, ACEI/ARB usage was <1%. Multivariate analysis revealed that comorbidities, region, hospital tier, physician specialty and patient′s educational level were associated with ACEI/ARB use.

Conclusion

In T2DM with hypertension and albuminuria in China, more than half of them were not treated with ACEI/ARB. This real world evidence suggests that the current treatment for patients with diabetes coexisting with hypertension and albuminuria in China is sub-optimal.

语种: 英语
所属项目编号: 201002010 ; 2011BAI10B05 ; NSFC: 81300569
项目资助者: Merck Sharp Dohme (China) ; Health Industry Special Scientific Research Projects, Ministry of Health ; National Science and Technology Ministry ; Natural Science Foundation of China
WOS记录号: WOS:000349914000012
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/64270
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China
2.Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing 100871, Peoples R China
3.Peking Univ, Dept Cardiol, Peoples Hosp, Beijing 100871, Peoples R China
4.VitalStrateg Res Inst, Berwyn, PA USA

Recommended Citation:
Xie, Qionghong,Hao, Chuan-Ming,Ji, Linong,et al. ACEI/ARB Underused in Patients with Type 2 Diabetes in Chinese Population (CCMR-3B Study)[J]. PLOS ONE,2015,10(2).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Xie, Qionghong]'s Articles
[Hao, Chuan-Ming]'s Articles
[Ji, Linong]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Xie, Qionghong]‘s Articles
[Hao, Chuan-Ming]‘s Articles
[Ji, Linong]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace